68788-0536 NDC - TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE

Drug Information

Product NDC: 68788-0536

Proprietary Name: Trimethoprim sulfate and Polymyxin B sulfate

Non Proprietary Name: Trimethoprim sulfate and Polymyxin B sulfate

Active Ingredient(s):
  • 1 mg/mL TRIMETHOPRIM SULFATE;
  • 10000 [USP'U]/mL POLYMYXIN B SULFATE


Administration Route(s): OPHTHALMIC

Dosage Form(s): SOLUTION

Pharmacy Class(es):
  • Dihydrofolate Reductase Inhibitor Antibacterial [EPC];
  • Dihydrofolate Reductase Inhibitors [MoA];
  • Cytochrome P450 2C8 Inhibitors [MoA];
  • Organic Cation Transporter 2 Inhibitors [MoA];
  • Polymyxin-class Antibacterial [EPC];
  • Polymyxins [CS]

Labeler Information

Labeler Name: Preferred Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA065006
Marketing Category: ANDA
Start Marketing Date:10/20/2015

Package Information

No. Package Code Package Description Billing Unit
168788-0536-110 mL in 1 BOTTLE, DROPPER (68788-0536-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC68788-0536The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMETrimethoprim sulfate and Polymyxin B sulfateThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMETrimethoprim sulfate and Polymyxin B sulfateThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESOLUTIONThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEOPHTHALMICThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE10/20/2015This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERANDA065006This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEPreferred Pharmaceuticals Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMETRIMETHOPRIM SULFATE; POLYMYXIN B SULFATEThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH1; 10000 
ACTIVE INGRED UNITmg/mL; [USP'U]/mL 
PHARM CLASSESDihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA],Polymyxin-class Antibacterial [EPC],Polymyxins [CS] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 11/18/2019